PMDA Review Report: Flexible Discussions Needed for Eligibility of AstraZeneca Vaccine

May 24, 2021
The Pharmaceuticals and Medical Devices Agency (PMDA) released its review reports for two COVID-19 vaccines developed by AstraZeneca and Moderna on May 21 upon their approval the same day. It was revealed that reviewers urged “flexible” discussions on the scope...read more